KEVEYIS Drug Patent Profile
✉ Email this page to a colleague
When do Keveyis patents expire, and what generic alternatives are available?
Keveyis is a drug marketed by Xeris and is included in one NDA.
The generic ingredient in KEVEYIS is dichlorphenamide. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the dichlorphenamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Keveyis
A generic version of KEVEYIS was approved as dichlorphenamide by TORRENT on December 29th, 2022.
Summary for KEVEYIS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Patent Applications: | 3,804 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for KEVEYIS |
| What excipients (inactive ingredients) are in KEVEYIS? | KEVEYIS excipients list |
| DailyMed Link: | KEVEYIS at DailyMed |
Pharmacology for KEVEYIS
| Drug Class | Carbonic Anhydrase Inhibitor |
| Mechanism of Action | Carbonic Anhydrase Inhibitors |
US Patents and Regulatory Information for KEVEYIS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xeris | KEVEYIS | dichlorphenamide | TABLET;ORAL | 011366-002 | Aug 7, 2015 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
